Gynecological disease
Conditions
Interventions
remimazolam group:Propofol 2-10 mg/kg/h
Remifentanil 0.1-0.2 µg/kg/min
Rocuronium 0.2 mg/kg/h
Propofol :Propofol 2-10 mg/kg/h
Remifentanil 0.1-0.2 µg/kg/min
Normal saline 0.2 ml/kg/h
Sponsors
The First Affiliated Hospital of Wannan Medical College Yijishan Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >=18 years old; 2. ASA classification I-II; 3. Signed informed consent
Exclusion criteria
Exclusion criteria: 1. The patient refuses to participate in the study; 2. Body mass index higher than 30; 3. Recent history of drug abuse; 4. Contraindications or allergy to remimazolam; 5. Cognitive impairment or inability to communicate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of sleep disorders; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative Day 1 Sleep-Related Indicators;Prevalence of sleep disorders;Anxiety and Depression Rating Scale Scores;Visual Analog Scale Score;Postoperative Recovery Quality Score QOR-15;Time of anesthesia awakening;Surgery time;Anesthesia time;PACU dell time;Intraoperative hemodynamics;Rescue dose of analgesics within 24 hours after surgery;nausea and vmiting score;total amount of anesthetic drugs; | — |
Countries
China
Contacts
Public ContactLu Meijing
The First Affiliated Hospital of Wannan Medical College Yijishan Hospital
Outcome results
None listed